APA (7th ed.) Citation

Bougen-Zhukov, N., Decourtye-Espiard, L., Mitchell, W., Redpath, K., Perkinson, J., Godwin, T., . . . Guilford, P. (2022). E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. Cancers, 14(7), 1609. https://doi.org/10.3390/cancers14071609

Chicago Style (17th ed.) Citation

Bougen-Zhukov, Nicola, Lyvianne Decourtye-Espiard, Wilson Mitchell, Kieran Redpath, Jacqui Perkinson, Tanis Godwin, Michael A. Black, and Parry Guilford. "E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib." Cancers 14, no. 7 (2022): 1609. https://doi.org/10.3390/cancers14071609.

MLA (9th ed.) Citation

Bougen-Zhukov, Nicola, et al. "E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib." Cancers, vol. 14, no. 7, 2022, p. 1609, https://doi.org/10.3390/cancers14071609.